The distinct signatures of VEGF and soluble VEGFR2 increase prognostic implication in gastric cancer

Por Ock, Chan-Young, Nam, Ah-Rong, Bang, Ju-Hee, Kim, Tae-Yong, Lee, Kyung-Hun, Han, Sae-Won, Im, Seock-Ah, Kim, Tae-You, Bang, Yung-Jue, Oh, Do-Youn
Publicado no Am J Cancer Res (2015)

Soluble programmed death-ligand 1 (sPDL1) and neutrophil-to-lymphocyte ratio (NLR) predicts survival in advanced biliary tract cancer patients treated with palliative chemotherapy

Por Ha, Hyerim, Nam, Ah-Rong, Bang, Ju-Hee, Park, Ji-Eun, Kim, Tae-Yong, Lee, Kyung-Hun, Han, Sae-Won, Im, Seock-Ah, Kim, Tae-You, Bang, Yung-Jue, Oh, Do-Youn
Publicado no Oncotarget (2016)

Therapeutic implication of HER2 in advanced biliary tract cancer

Por Nam, Ah-Rong, Kim, Ji-Won, Cha, Yongjun, Ha, Hyerim, Park, Ji Eun, Bang, Ju-Hee, Jin, Mei Hua, Lee, Kyung-Hun, Kim, Tae-Yong, Han, Sae-Won, Im, Seock-Ah, Kim, Tae-You, Oh, Do-Youn, Bang, Yung-Jue
Publicado no Oncotarget (2016)